IFF: Volume-led growth lifted adjusted EBITDA, but asset-sale impairments drove a Q3 loss

What happened

Third-quarter sales rose 4% on a reported basis and Adjusted Operating EBITDA grew 5%. A $236M impairment on assets held for sale contributed to a $55M net loss. Volume growth occurred in all continuing segments, and the Food Ingredients sale and buyback program shape capital allocation.

Confirmed

Global impact / market context

The higher sales and operating profit show the core business selling more products, but the $236M write-down on assets held for sale pushed the company to a net loss. That reduces reported profit and book value even though day-to-day operations improved.

Analyst inference

A company selling a business must mark those assets at the lower value it expects to receive, and the $236M impairment reflects that gap. Investors weighing the stock must separate improving operating results from one-time losses tied to the Food Ingredients sale.

Analyst inference

What to watch

1. Track whether volume growth continues across all continuing segments, since higher volumes drove both the 4% sales increase and the 5% Adjusted Operating EBITDA growth this quarter. Confirmed
2. Watch the Food Ingredients sale process, including whether final proceeds differ from the $236M impairment already recorded, which would change the loss tied to assets held for sale. Proposed
3. Monitor how much cash the buyback program uses, because spending on repurchases reduces cash available for debt repayment or reinvestment in the remaining business segments. Analyst inference

Evidence

• Original source link unavailable